raziel therapeutics
Raziel Therapeutics is a clinical-stage pharmaceutical company
raziel therapeutics has raised €20M across 1 funding round from 1 investor, most recently a Series C round in Oct 2019. Based in Rehovot, Israel; active in Healthtech. Data as of 28 Oct 2026.
Rehovot, Israelwww.raziel-therapy.com ↗
Total raised
€20M
€20,203,875
Funding rounds
1
Investors
1
distinct backers
Active since
2019-10
latest 2019-10
Funding by year
EUR raised per yearraziel therapeutics — funding by year — interactive chart.
Data table
| raziel therapeutics — funding by year | |
|---|---|
| 2019 | €20M |
Signals
High confidenceRaise-next likelihood9
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series C | €20M | Pontifax Funds | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData